Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001832334-20-000001
Filing Date
2020-11-16
Accepted
2020-11-16 14:10:33
Documents
1
Effectiveness Date
2020-11-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7071
  Complete submission text file 0001832334-20-000001.txt   8114
Mailing Address 5125 MACARTHUR BLVD. NW, #20 WASHINGTON DC 20016
Business Address 5125 MACARTHUR BLVD. NW, #20 WASHINGTON DC 20016 1 (925) 822-6461
Cyrano Therapeutics, Inc. (Filer) CIK: 0001832334 (see all company filings)

EIN.: 461891229 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-380646 | Film No.: 201315517